Cymabay Therapeutics Inc logo

Cymabay Therapeutics Inc Share Price (NASDAQ: CBAY)

▲

-32.48

(-100%)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 21 Mar 2024

Check the interactive Cymabay Therapeutics Inc Stock chart to analyse performance

Cymabay Therapeutics Inc Key Stats

Check Cymabay Therapeutics Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$32.48
Open
$32.49
Market Capitalization
$3.7B
Today's Volume
$8.4M
Revenue TTM
$31.1M
EBITDA
$-101.0M
Earnings Per Share (EPS)
$-0.99
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-64.17%

Global Institutional Holdings in Cymabay Therapeutics Inc

  • Name

    Holdings %

  • venBio Select Advisor LLC

    9.68%

  • BlackRock Inc

    8.37%

  • RA Capital Management, LLC

    6.05%

  • Vanguard Group Inc

    5.49%

  • HHG PLC

    5.32%

  • T. Rowe Price Associates, Inc.

    3.89%

Analyst Recommendation on Cymabay Therapeutics Inc Stock

Rating
Trend

Buy

    94%Buy

    5%Hold

    0%Sell

Based on 19 Wall street analysts offering stock ratings for Cymabay Therapeutics Inc(by analysts ranked 0 to 5 stars)

About Cymabay Therapeutics Inc

CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta for the treatments of primary biliary cholangitis (PBC). The company also develops MBX-2982, a G protein-coupled receptor 119 (GPR119) agonist, in subjects with type 1 diabetes. It has a license agreement with ABW Cyclops SPV LP to support development of seladelpar for the treatment of PBC. The company was formerly known as Metabolex, Inc. CymaBay Therapeutics, Inc. was incorporated in 1988 and is headquartered in Fremont, California.
Organization
Cymabay Therapeutics Inc
Employees
101
CEO
Mr. Sujal A. Shah
Industry
Health Technology

Important FAQs about investing in CBAY Stock from India :

What is Cymabay Therapeutics Inc share price today?

Cymabay Therapeutics Inc share price today is as on at the close of the market. Cymabay Therapeutics Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Cymabay Therapeutics Inc share?

Cymabay Therapeutics Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Cymabay Therapeutics Inc stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Cymabay Therapeutics Inc Stock (CBAY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cymabay Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cymabay Therapeutics Inc Shares .

What is the minimum amount required to buy Cymabay Therapeutics Inc Stock (CBAY) from India?

Indian investors can start investing in Cymabay Therapeutics Inc (CBAY) shares with as little as ₹87.7613 or $1 (as of September 18, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹877.61 in Cymabay Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025). Learn more about fractional shares .

What are the returns that Cymabay Therapeutics Inc has given to Indian investors in the last 5 years?

Cymabay Therapeutics Inc stock has given 0.0% share price returns and 19.34% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?